Summary. To assess the risk and possible mechanisms ofhypoglycaemia during moderate exercise in Type I (insulin-dependent) diabetic patients receiving constant insulin infusion, five insulin-dependent male diabetic patients were exercised 18 h after their last meal and 30 h after their last injection of intermediate acting insulin. Intravenous insulin was initially delivered via a closed-loop infusion system programmed to lower mean blood glucose from 11.3 _+ 1.8 to 4.8 + 0.4 mmol/1 over approximately 3.5 h. Blood glucose was then maintained at this level for 4 h. At this time, the dosed-loop infusion was discontinued and replaced by an open-loop system. The average amount of insulin infused per rain during the 4 h normoglycaemic closed-loop period was calculated and this amount was infused at a constant rate during both a 30 min period of exercise on a bicycle ergometer (approximately 65% maximum oxygen uptake) and a 30 min rest period which followed. Five nondiabetic males served as control subjects. Despite significantly higher free insulin concentrations (p < 0.05) and identical preexercise blood glucose concentrations, blood glucose rose during exercise only in the diabetic group (0.5 _+ 0.2 retool/1; p < 0.01). Changes in the serum concentrations of lactate, glycerol, glucagon, cortisol, non-esterified fatty acids and growth hormone were similar in the two groups and did not account for the increment of blood glucose in the diabetic patients. Betahydroxybutyrate concentrations were, however, higher in the diabetic patients at the onset of exercise (p < 0.01) and decreased significantly more than the control subjects during exercise. We conclude that exercise under these conditions in diabetic patients is not attended by hypoglycaemia.
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One method of normalizing blood glucose is an openloop insulin infusion pump which delivers insulin at a constant rate with pulses of insulin before meals [1, 2] without immediate regard to the concentration of blood glucose. This therapy may put patients at risk of hypoglycaemia: those most at risk would appear to be Type I patients whose exercise and meal plans may be most unpredictable.
There are several reasons why exercise might cause a fall in blood glucose in diabetic subjects who receive a constant insulin infusion. Firstly, free insulin concentrations are usually higher in the such patients compared with non-diabetic subjects [3] . Secondly, unlike normal subjects in whom insulin release declines during exercise [4] , there is no decline in the rate of insulin infusion given via a constant open-loop infusion apparatus. Thus, high insulin levels in combination with increased glucose consumption could be expected to produce hypoglycaemia. On the other hand, portal vein insulin concentrations produced by these devices may be low, relative to those in the non-diabetic. Thus, despite increased pcripheral concentrations, the amount of insulin reaching the liver may be insufficient to regulate hepatic glucose production appropriately. Under these circumstances, blood glucose may even rise during moderate exercise.
The purpose of this study was to assess the effect of exercise in Type I diabetic patients receiving a constant, open-loop insulin infusion programmed to achieve and maintain normoglycaemia while at rest.
Subjects and Methods
The study was conducted at the University of Chicago's Clinical Research Centre. Informed consent was obtained from each subject before the investigation. Five male Type I diabetic patients (age 30 _ 5 years, duration of diabetes 8 _ 2 years), without clinically detectable complications, and five age-matched, healthy male control subjects were studied. Insulin regimens of the diabetic subjects are shown in Table 1 . All subjects were accustomed to moderate, erratic, physical exercise but none engaged in regular strenuous, competitive exercise. The subjects were instructed to eat their normal diet until the evening before the study. Each diabetic took his normal morning insulin on the day before the study, but, thereafter, intermediate and long-acting insulins were withheld. 
Exercise
To determine the ergometer tension that would give a pulse rate of approximately 150 beats/rain when pedalling at 20-25 kin/h, each subject exercised before the study on a stationary bicycle ergometer for 7 min. This rate of exercise corresponds to approximately 65% of maximum oxygen uptake [5] . This tension and pedalling rate were kept constant throughout the 30-min exercise period. During rest periods, subjects were in a sitting position.
Glucose Controlled Insulin Infusion System
The artificial B cell [Biostator, glucose-controlled insulin infusion system], Life Science Instruments, Miles Laboratories, Elkhart, Indiana, USA], and the regulating algorithms have been described fully elsewhere [6, 7] . Briefly, blood is continuously withdrawn at a rate of 2 ml/h through a double lumen cannula placed in an antecubital vein. On the basis of continuous whole blood glucose analyses, the machine infuses insulin and/or glucose to maintain normoglycaemia. In this experiment only insulin was infused.
Experimental Protocol
After an overnight fast of at least 12 h and 24 h after the last injection of intermediate acting insulin, three indwelling cannulae were inserted into arm veins of each diabetic subject. After 15 min rest, baseline blood samples were obtained. The glucose-controlled insulin infusion was started and blood glucose concentrations were decreased to approximately 4.4-5.0 retool/1. The average time required to normalize the blood glucose was 3.5 h. Blood glucose concentrations were maintained at this level for at least I h when a second set of blood samples was obtained. Blood glucose was then maintained at this level for 4 h by infusion of insulin according to the glucose-controlled insulin infusion system algorithm. The average rate of the insulin infusion needed during these 4 h was calculated (68 +_ 25 uU 9 kg -1 9 min -1) and this amount was then given throughout the 30-rain exercise and post-exercise rest period as an open-loop, constant-rate infusion. Non-diabetic control subjects were studied after an overnight fast during a similar protocol. They were not attached to the glucose-controlled insulin infusion system but had one indwelling cannula in a forearm vein to facilitate blood collection. A volume of normal saline was infused equal to that administered to the diabetic group.
Analytical Methods
Glucose concentrations were determined by kinetic assay using hexokinase [8] . Free insulin and C-peptide [9] were determined by radioimmunoassay. Glucagon was assayed using 30K antiserum [10] . A colorometric method was used to measure non-esterified fatty acid concentrations [11] . Enzymatic methods were used to determine lactate,/3-hydroxybutyrate and glycerol concentrations [12] . Growth hormone [13] and cortisol [14] were determined using radioimmunoassay and competitive protein binding assay, respectively.
The sensitivities and intra-assay coefficients of variation for several of the assays were, respectively: insulin 1.0 mU/1, 5.7%; C-peptide 0.02 pmol/l, 7.5%; glucagon 5 pg/ml, 8.8%; fl-hydroxybutyrate 20 ~mol/1, 4.4%; glycerol 20 ~mol/1, 4.5%; growth hormone 0.07 ng/ ml, 4.0%; cortisol 0.1 nmol/1, 2.0%.
Statistical Methods
Results are expressed as mean __+_ SEM. Significance of the difference between two mean values was calculated using the Student's t-test. The mean change between any two time points was calculated by averaging the changes for each subject (paired t-test).
Results
To achieve euglycaemia in the diabetic subjects, an average of 3 620 _+ 932 mU of insulin was required. Once euglycaemia was achieved, 1065 _+ 350 mU of insulin (68 + 26 lxU 9 kg-~ 9 rain-1) were required to maintain the plasma glucose concentrations between 4.4 and 5.0 mmol/1.
There were no significant differences in heart rates between the normal and diabetic subjects at any time point (Table 2 ). The most rapid pulse for both diabetic (154 +_ 8 beats/min) and control subjects (155 + 8 beats/ rain) occurred at the end of the exercise period.
Blood glucose values during the study are shown in Figure 1 . At the onset of the experiment the blood glucose concentrations of the diabetic patients (11.3 + 1.8 mmol/1) were significantly higher than the normal subjects (5.1 _+ 0.1; p < 0.02). Thereafter, there were no significant differences in blood glucose levels between the two groups before exercise. However, the groups differed in their response to exercise. The mean rise in blood glucose for the diabetic patients (0.6 _+ 0.2 mmol/1) reached statistical significance (p < 0.01), while that of the control subjects (0.1 +_ 0.1 mmol/1) did not. These changes were also significantly different when the two groups were compared with each other (p < 0.02). During the 30 rain of rest following exercise, plasma glucose continued to rise in the diabetic group, but only slightly (0.2 _+ 0.1 mmol/1).
The control group had a gradual but significant decline in the concentration ofimmunoreactive free insulin during the pre-exercise period (p < 0.05) ( Table 2) . A further decline was observed during exercise. Free immunoreactive insulin concentrations in the diabetic group were several-fold higher at all time points com-pared with the control group and were constant through14z ~-out the experimental period (p < 0.05).
The non-esterified fatty acid (NEFA) concentrations (Fig. 2) There were no significant differences in the glycerol concentrations between the two groups (Fig.2) . The mean rise during exercise tended to be higher in the diabetic (0.32 ___ 0.06 mmol/1; p < 0.001) than the control Fig.2 . Serum concentrations ofnon-esterified free fatty acids (NEFA), glycerol and/3-hydroxybutyrate in the diabetic patients ( 9149 ) and control subjects ( 9149 are shown. * p < 0.05; ** p < 0.01 significant differences between groups groups (0.20 + 0.08 mmol/1; p < 0.05), but the difference between the groups was not significant.
There were no detectable differences between the two groups at any time in concentrations of lactate (Table 2 ). There was a significant mean rise during exercise in both the diabetic (3.3 +_ 0.6 mmol/1; p < 0.01) and control groups (5.4 + 1.2 mmol/1; p < 0.01). These changes, however, were not significantly different from one another. After the 30-min post-exercise rest period, lactate concentrations in both groups returned to preexercise values.
In one of the five diabetic patients a circulating antiglucagon antibody prevented measurements of plasma glucagon. In the others pre-exercise glucagon concentrations tended to be lower than those of the control subjects (Table 2 ), but the difference between the groups was not significant. In both groups, plasma glucagon concentrations rose during exercise, but the increment was not significant. C-peptide concentrations in the diabetic patients (data not shown) were at or below the detection limits of the assay (0.02 pmol/1) throughout the protocol.
The pre-exercise concentrations of growth hormone tended to be higher in the diabetic subjects , although the differences were not significant ( Table 2 ). There was a significant rise in the growth hormone concentrations during exercise in both the diabetic (15 + 6 ng/ml; p < 0.05) and the control groups (24 + 7 ng/ml; p < 0.01). Serum cortisol concentrations at each time point were not significantly different between the two groups ( Table 2 ). There was a significant increase during exercise in both the diabetic (193 +_ 63 nmol/l; p < 0.05) and control groups (130 ___ 33 nmol/1;p < 0.02).
Discussion
Although the blood glucose in normal subjects can increase by 1.1 to 1.7 mmol/1 with vigorous exercise [4] and decrease 0.6 to 2.2 mmol/1 with exercise continuing beyond 90 min [15, 16] , there is little change during shortterm, mild or moderate exercise [4, 17] . This is due to the equalization of glucose production and utilization.
In diabetic subjects and experimental animals, the concentration of circulating insulin present during exercise is an important factor in determining whether blood glucose will rise, fall or remain constant during exercise. A small, but critical concentration of insulin is essential for stimulation of glucose utilization during exercise [18, 19] . When diabetic dogs were subjected to exercise 27 h after their last insulin injection, blood glucose rose sharply due to increased glucose production without a concomitant increase in glucose utilization by exercising muscle [20] . Similar elevations in plasma glucose concentrations have also been reported in insulin deficient diabetic patients during exercise [21] [22] [23] .
In contrast to the insulin-deficient model of exercise, over-insulinized diabetic animals exhibit a fall in plasma glucose during exercise. When depancreatectomized dogs are given a subcutaneous injection of insulin before exercise, plasma insulin levels are elevated, and there is a significant fall in plasma glucose concentrations due to a mismatch of glucose uptake (which was similar to normal dogs during exercise) and hepatic glucose production (which was decreased from that found in normal dogs) [24] [25] [26] . Zinman et al. [27] demonstrated this same effect in diabetic subjects receiving subcutaneous insulin injections before exercise. Thus, appropriate insulin concentrations during exercise allow optimal glucose utilization by peripheral tissues and appropriate regula-tion of hepatic glucose production. There is then equilization of glucose production and utilization during exercise, and blood glucose concentrations are relatively stable [28, 29] . In support of this concept, Zinman et al. [30] have shown that exercising diabetic patients have stable blood glucose concentrations during constant insulin infusion which produces blood glucose concentrations of 6.7 mmol/1. Under these circumstances, glucose production and disappearance rose synchronously and were similar to the responses observed in normal subjects.
In light of these observations in the exercising diabetic patients, the concentrations of free immunoreactive insulin achieved in this study are critical in interpreting the glycaemic response we have described. Obviously, adequate amounts of insulin were infused to produce stable euglycaemia in each diabetic subject while at rest. Furthermore, the concentrations of free immunoreactive insulin in the diabetic subjects were similar to those reported by others under similar circumstances [3] . Yet, despite apparently adequate insulinization, the glycaemic response during exercise reflects a mild imbalance between glucose production and consumption. Our data do not permit us to determine whether glucose production was inadequately suppressed, peripheral glucose consumption relatively diminished, or whether both mechanisms contributed to the glycaemic response.
The rise in plasma glucose in the diabetic subjects during exercise may have been due to greater amounts or greater effects of circulating stress hormones. Those we measured (glucagon, cortisol, growth hormone), however, were not different in the control and diabetic groups, at the beginning or end of exercise. Although peripheral concentrations do not necessarily reflect portal concentrations or tissue sensitivity, these data offer no support for the contention that these hormones accounted for the observed rise in plasma glucose. A possible role for catecholamines cannot be excluded. Gluconeogenic precursors or other non-carbohydrate fuels may have also contributed to the exercise-induced glycaemia. In particular, our data suggest relatively greater consumption of fl-hydroxybutyrate by the diabetic group. The pattern of response in both groups was similar and consisted of a decline in fl-hydroxybutyrate concentration during exercise and an increase after exercise. The pattern is consistent with the observations of other investigators [29, 31] . The diabetic patients, however, had markedly higher levels offl-hydroxybutyrate throughout the experiment and a relatively greater decrease during exercise suggesting increased utilization of ketone bodies as an energy substrate [32, 33] . Higher serum NEFA concentrations and comparatively lower portal to systemic insulin ratios (as a consequence of intravenous, rather than intraportal infusion of insulin) may explain this observation. An increased utilization of fl-hydroxybutyrate in the diabetic group may have led to diminished glucose utilization and, at least in part, contributed to the exercise-induced rise in blood glucose. 341 The higher NEFA concentrations found in the diabetic group have been reported by other investigators [21, 29] . Fasting probably caused the NEFA levels to rise in both groups before exercise while the effect of the insulin infusion tended to narrow the difference between the groups. The concentrations of glycerol before exercise and the response of this substrate during exercise was similar in both groups and consistent with results previously reported for normal subjects [17, 31] .
Other studies have demonstrated an abnormally high lactate concentration during exercise in diabetic subjects [21, 29, 31] . During exercise with constant insulin infusion, Murray et al. [31] reported lactate levels in diabetic patients twice as high as in healthy controls. There were, however, no differences in the lactate concentrations recorded during exercise in the two groups in the present study. This may have been due to the achievement of normoglycaemia.
Open-loop insulin infusion pumps can maintain near-normal blood glucose levels in Type I diabetic patients at rest or during moderate activity [1, 2] . In this study, we have extended the results of Zinman et al. [30] to show that short-term, continuous, intravenous insulin administration does not produce hypoglycaemia in fasting patients during or immediately after exercise, even when normoglycaemia is maintained. Further study is needed before the results of this experience can be extended to diabetic subjects undergoing chronic insulin infusion therapy and stresses other than exercise. Adaptation of muscle, fat or liver to much more prolonged maintenance of euglycaemia may result in different responses. Nevertheless, the assumption that hypoglycaemia will be an invariable occurrence when normoglycaemic diabetic patients engage in vigorous exercise or are subjected to stress is certainly not warranted.
